论文部分内容阅读
目的:分析来曲唑治疗男性少弱精子症的临床效果。方法:将2013年1月-2017年2月160例男性少弱精子症患者根据数字随机表法分两组各80例。常规组用十一酸睾丸酮胶囊治疗,来曲唑组则给予来曲唑治疗。比较两组男性少弱精子症治疗效果;干预前后患者精子浓度、精子正常形态率、雌二醇水平、睾酮水平。结果:来曲唑组男性少弱精子症治疗效果高于常规组,P<0.05;干预前两组精子浓度、精子正常形态率、雌二醇水平、睾酮水平相近,P>0.05;出院时来曲唑组精子浓度、精子正常形态率、雌二醇水平、睾酮水平优于常规组,P<0.05。结论:来曲唑治疗男性少弱精子症的临床效果确切,可有效改善患者病情,增加精子活力,值得推广。
Objective: To analyze the clinical effect of letrozole in the treatment of oligozoospermia in men. Methods: From January 2013 to February 2017, 160 male patients with oligozoospermia were divided into two groups of 80 cases according to the digital random table. The conventional group was treated with testosterone undecanoate, while the letrozole group was given letrozole treatment. The treatment effect of male oligozoospermia was compared between two groups. The sperm concentration, normal sperm morphology, estradiol level and testosterone level before and after intervention were compared. Results: The treatment effect of levofloxacin in male letrozole group was higher than that in the conventional group (P <0.05). The sperm concentration, normal sperm morphology, estradiol level and testosterone level in the two groups before intervention were similar (P> 0.05) The concentration of sperm, normal sperm morphology, estradiol level and testosterone level in the trazole group were better than those in the conventional group (P <0.05). Conclusion: Letrozole treatment of male oligoasthenospermia clinical effect is exact, can effectively improve the patient’s condition, increase sperm motility, it is worth promoting.